drugset
Drugs / Tranexamic Acid
last change 3 days ago re-read 2 minutes ago

Tranexamic Acid

also known as TXA · Cyklokapron · EXACYL · Kapron · Capron · LB1148 · Transamin · Cyclokapron · +25 more

Small molecule

Developed for
hemorrhagic disease · osteoarthritis, knee · hyperpigmentation of the skin · anemia · menstrual disorder · rotator cuff syndrome · bone disorder · osteoarthritis
+121 more · osteoarthritis, hip · arthropathy · bleeding disorder, vascular-type · coronary artery disorder · leiomyoma · traumatic brain injury · uterine disorder · benign prostatic hyperplasia · chronic rhinosinusitis · COVID-19 · craniosynostosis · hematopoietic and lymphoid cell neoplasm · ileus · placenta praevia · venous thromboembolism · blood coagulation disease · intracerebral hemorrhage · nephrolithiasis · pregnancy disorder · prostate cancer · scoliosis · acquired coagulation factor deficiency · active peptic ulcer disease · cardiac valvular defect · cirrhosis of liver · eyelid disorder · fibrinolytic defect · head and neck neoplasm · hemophilia · hereditary hemorrhagic telangiectasia · infectious disease with sepsis · inflammatory disease · lower respiratory tract disorder · lumbar spinal stenosis · meningioma · ovarian cancer · pelvic organ prolapse · shoulder impingement syndrome · tonsillitis · urinary bladder cancer · uterine corpus leiomyoma · vascular hemostatic disease · von Willebrand disease (hereditary or acquired) · abdominal aortic aneurysm · acute myeloid leukemia · adolescent idiopathic scoliosis · aortic disorder · arteriovenous hemangioma/malformation · chronic liver failure · chronic pain syndrome · colon carcinoma · conjunctival disorder · developmental dysplasia of the hip · disease of orbital part of eye adnexa · endometrial disorder · Ewing sarcoma of bone · female breast carcinoma · female reproductive system neoplasm · gastric cancer · gastric neoplasm · hemarthrosis · hemophilia A · hepatocellular carcinoma · hyperpigmentation of eyelid · hypotensive disorder · lichen planus pigmentosus · lung disorder · lymphedema · lymphocele · malignant pancreatic neoplasm · melanoma · meningitis · metastatic malignant neoplasm in the spinal cord · myelodysplastic syndrome · myelodysplastic/myeloproliferative neoplasm · neoplasm of esophagus · obstetric disorder · osteogenesis imperfecta · osteoporosis · osteosarcoma · palmar fibromatosis · perianal hematoma · phlebectasia of lips · placenta accreta · placental abruption · platelet disorder, undefined · pneumonia · polyp of large intestine · skin disorder · skin squamous cell carcinoma · spinal stenosis · stomach polyp · thrombocytopenia · tumor of duodenum · upper digestive tract disorder · urethral stricture · urinary tract obstruction · varicose disease · vertebral column disorder · adenoid hypertrophy · alveolar periostitis · angiodysplasia of intestine · bronchial disorder · chronic urticaria · colorectal cancer · congenital heart disease · epilepsy · esophageal varices with bleeding · hereditary angioedema · intervertebral disk degenerative disorder · musculoskeletal system cancer · nosocomial infection · obesity disorder · skin infection · skin pigmentation disorder · soft tissue sarcoma · spinal cord disorder · spinal cord injury · subarachnoid hemorrhage · toe, misshapen · uterine anomalies
Investigated by
Cairo University · Assiut University · London School of Hygiene and Tropical Medicine · Aswan University Hospital · Chinese Academy of Medical Sciences, Fuwai Hospital · NYU Langone Health
+509 more · National Cheng-Kung University Hospital · Northwestern University · University Health Network, Toronto · Ferring Pharmaceuticals · St. Olavs Hospital · University of Alabama at Birmingham · Indonesia University · Konkuk University Medical Center · Sant Pau Research Institute · Sunnybrook Health Sciences Centre · Al-Azhar University · Assaf-Harofeh Medical Center · Bayer · Campbell Clinic · Canadian Institutes of Health Research (CIHR) · Clinical Hospital Centre Zagreb · Corewell Health West · George Washington University · Hamilton Health Sciences Corporation · Henry Ford Health System · Hospital for Special Surgery, New York · McMaster University · Ministry of Health, France · Montefiore Medical Center · National Heart, Lung, and Blood Institute (NHLBI) · Ottawa Hospital Research Institute · Pfizer · RenJi Hospital · Rush University Medical Center · Tanta University · Thammasat University · University of California, San Francisco · University of Wisconsin, Madison · Washington University School of Medicine · Yonsei University · Albany Medical College · Asan Medical Center · Azienda U.S.L. 1 di Massa e Carrara · Benha University · Boston Children's Hospital · Dalhousie University · Daniel Nishijima, MD, MAS · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · First Affiliated Hospital, Sun Yat-Sen University · HaEmek Medical Center, Israel · Haseki Training and Research Hospital · Hebei Medical University Third Hospital · Hua Luo · King Edward Medical University · Korea Health Industry Development Institute · M.D. Anderson Cancer Center · Massachusetts General Hospital · Meir Medical Center · Monash University · Mount Sinai Hospital, Canada · Nanfang Hospital, Southern Medical University · National Health and Medical Research Council, Australia · Oregon Health and Science University · Palisade Bio · Pediatric Emergency Care Applied Research Network · Population Health Research Institute · Rabin Medical Center · Rawalpindi Medical College · Second Affiliated Hospital of Guangzhou Medical University · Second Affiliated Hospital, School of Medicine, Zhejiang University · Seoul National University Hospital · Shanghai Jiao Tong University School of Medicine · Stanford University · Taipei Veterans General Hospital, Taiwan · The First Affiliated Hospital of Zhengzhou University · The Hospital for Sick Children · The Physicians' Services Incorporated Foundation · The University of Texas Health Science Center at San Antonio · The University of Texas Health Science Center, Houston · all 515 on the full record

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) CYKLOKAPRON — 1986-12-30 fda.gov ↗

Trials 446 · started per year

today
US approved 1986
1
1
1
5
7
2
9
9
10
7
13
18
21
23
26
18
35
26
30
44
31
30
31
20
28
1986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 018 trials
Phase 0 NCT07565753 Jul 2026 → Sep 2027 expected bleeding disorder, vascular-type, tonsillitis The University of Texas Health Science Center at San Antonio Recruiting No outcome recorded
Phase 0 NCT07362992 Jul 2026 → Dec 2028 expected — Wolfson Medical Center Recruiting No outcome recorded
Phase 0 NCT06580509 Feb 2026 → Sep 2027 expected bleeding disorder, vascular-type, tonsillitis The University of Texas Health Science Center at San Antonio Recruiting No outcome recorded
Phase 0 NCT06725732 Jan → Dec 2025 overdue — Assiut University Recruiting No outcome recorded
Phase 0 NCT06345833 Jul 2024 → Jul 2026 overdue hemophilia, hemorrhagic disease University of Minnesota Recruiting No outcome recorded
Phase 0 NCT06097611 Nov 2023 → Nov 2024 — Assiut University Unknown No outcome recorded
Phase 0 NCT04630886 Jun 2021 → Jan 2024 skin neoplasm Riley McLean Terminated No outcome recorded
Phase 0 NCT04797156 Mar 2021 → Aug 2024 — Icahn School of Medicine at Mount Sinai Completed No outcome recorded
Phase 0 NCT04541303 Oct 2020 → Dec 2021 — University of Missouri-Columbia Completed No outcome recorded
Phase 0 NCT04488367 Jul 2020 → Jul 2023 bone disorder Community Memorial Health System Unknown No outcome recorded
Phase 16 trials
Phase 1 NCT05774717 Apr 2023 → Apr 2029 expected — Vanderbilt University Medical Center Recruiting No outcome recorded
Phase 1 NCT03777488 Oct 2019 → Oct 2020 — London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 1 NCT04100447 Nov 2018 → Mar 2020 ileus Ronald Hurst, MD, FACS Completed No outcome recorded
Phase 1 NCT02561923 Aug 2015 → Jun 2016 — Janssen Scientific Affairs, LLC Completed No outcome recorded
Phase 1 NCT02620748 Mar 2015 → Feb 2018 leiomyoma George Washington University Completed No outcome recorded
Phase 1 NCT01683955 Jan → Nov 2013 anemia, osteoarthritis, hip Henry Ford Health System Completed No outcome recorded
Phase 1/210 trials
Phase 1/2 NCT06983886 May 2025 → Jun 2026 overdue — Ramathibodi Hospital Not yet recruiting No outcome recorded
Phase 1/2 NCT06997796 May → Dec 2025 overdue — Dr. Anne Conlin Recruiting No outcome recorded
Phase 1/2 NCT06023212 Dec 2023 → Jan 2026 overdue metastatic malignant neoplasm in the spinal cord Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting No outcome recorded
Phase 1/2 NCT04555343 Mar → Sep 2021 prostate cancer, urinary bladder cancer, urinary tract obstruction Fraser Health Completed No outcome recorded
Phase 1/2 NCT03875937 Sep 2019 → Feb 2020 — London School of Hygiene and Tropical Medicine Completed No outcome recorded
Phase 1/2 NCT03806556 Apr 2019 → Aug 2020 acquired coagulation factor deficiency, childhood malignant neoplasm, hemorrhagic disease, thrombocytopenia Meghan McCormick Terminated No outcome recorded
Phase 1/2 NCT02604719 Nov 2015 → May 2016 — Ahmed Alanwar Unknown No outcome recorded
Phase 1/2 NCT02688127 Aug 2015 → Feb 2016 pregnancy disorder Medical Research Council Completed No outcome recorded
Phase 1/2 NCT02350179 Jun 2014 → Apr 2015 perianal hematoma Ain Shams University Unknown No outcome recorded
Phase 1/2 NCT01085006 Sep 2009 → Aug 2010 hemorrhagic disease Tehran University of Medical Sciences Completed No outcome recorded
Phase 245 trials
Phase 2 NCT06665594 Dec 2025 → Nov 2026 expected — University of Wisconsin, Madison Recruiting No outcome recorded
Phase 2 NCT06718751 Oct 2025 → Oct 2029 expected — Baylor College of Medicine Not yet recruiting No outcome recorded
Phase 2 NCT06599762 Sep 2025 → Apr 2027 expected acute myeloid leukemia, myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm University of Manitoba Recruiting No outcome recorded
Phase 2 NCT07263841 Jun → Dec 2025 overdue hyperpigmentation of the skin King Edward Medical University Active not recruiting No outcome recorded
Phase 2 NCT06644079 May 2025 → Apr 2026 skin squamous cell carcinoma University of Florida Withdrawn No outcome recorded
Phase 2 NCT06657924 Feb 2025 → Sep 2027 expected hemorrhagic disease, intestinal disorder, thrombotic disease Kristen Ban Recruiting No outcome recorded
Phase 2 NCT06057675 Mar 2024 → Jun 2026 overdue skin cancer Vanderbilt University Medical Center Recruiting No outcome recorded
Phase 2 NCT03822793 Dec 2023 → Apr 2025 arthropathy University Hospital of Saint-Etienne Completed No outcome recorded
Phase 2 NCT05794321 Sep 2023 → May 2032 expected — University of California, San Francisco Recruiting No outcome recorded
Phase 2 NCT05802238 Apr 2023 → Nov 2024 bone disorder Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) Withdrawn No outcome recorded
Phase 2/314 trials
Phase 2/3 NCT07212452 Aug → Oct 2025 — University of Health Sciences Lahore Completed No outcome recorded
Phase 2/3 NCT06707051 Jan 2022 → Dec 2023 agranulocytosis, digestive system disorder, endometrial disorder, hemorrhagic disease +1 District Headquarters Teaching Hospital Sahiwal Completed No outcome recorded
Phase 2/3 NCT05047133 Sep 2021 → Jul 2022 overdue — Ascension Health Recruiting No outcome recorded
Phase 2/3 NCT04599205 Dec 2020 → Dec 2021 hyperpigmentation of the skin Assiut University Unknown No outcome recorded
Phase 2/3 NCT04430777 Jan 2019 → Feb 2020 — Total Definer Research Group Completed No outcome recorded
Phase 2/3 NCT03361345 Nov 2018 → Jan 2022 hyperpigmentation of the skin Wayne State University Withdrawn No outcome recorded
Phase 2/3 NCT04170088 Sep 2018 → May 2019 drug allergy Jinnah Postgraduate Medical Centre Completed No outcome recorded
Phase 2/3 NCT03353259 Nov 2017 → Feb 2021 — Oslo University Hospital Terminated No outcome recorded
Phase 2/3 NCT02866838 Dec 2016 → Sep 2021 intracerebral hemorrhage University Hospital, Basel, Switzerland Completed No outcome recorded
Phase 2/3 NCT03351686 Aug 2016 → Apr 2017 — Mansoura University Completed No outcome recorded
Phase 3104 trials
Phase 3 NCT04387305 Oct 2026 → Mar 2031 expected hemorrhagic disease, traumatic brain injury Daniel Nishijima, MD, MAS Not yet recruiting No outcome recorded
Phase 3 NCT07641946 Jul 2026 → Jul 2027 expected — Assiut University Not yet recruiting No outcome recorded
Phase 3 NCT07672158 Jul 2026 → Aug 2028 expected cerebral palsy Murdoch Childrens Research Institute Not yet recruiting No outcome recorded
Phase 3 NCT07474077 May 2026 → Dec 2027 expected — Sultan Qaboos University Not yet recruiting No outcome recorded
Phase 3 NCT06902714 Apr 2026 → Jul 2028 expected — University of Alabama at Birmingham Recruiting No outcome recorded
Phase 3 NCT07423156 Mar → Aug 2026 overdue placenta praevia Allama Iqbal Medical College Not yet recruiting No outcome recorded
Phase 3 NCT06519422 Sep 2025 → Aug 2028 expected anemia London School of Hygiene and Tropical Medicine Not yet recruiting No outcome recorded
Phase 3 NCT06337838 Jun 2025 → Feb 2027 expected acute kidney injury, chronic kidney disease, hemorrhagic disease Hamilton Health Sciences Corporation Recruiting No outcome recorded
Phase 3 NCT06070350 Nov 2024 → Jun 2028 expected — Philip Spinella Recruiting No outcome recorded
Phase 3 NCT06010368 Oct 2024 → Dec 2025 overdue — Cairo University Not yet recruiting No outcome recorded
Phase 4137 trials
Phase 4 NCT07685743 Sep 2026 → Mar 2028 expected osteoarthritis, hip, osteoarthritis, knee Oregon Health and Science University Not yet recruiting No outcome recorded
Phase 4 NCT07644923 Aug 2026 → Aug 2028 expected — NYU Langone Health Not yet recruiting No outcome recorded
Phase 4 NCT07696806 Jul 2026 → Jun 2027 expected hyperpigmentation of the skin Sameh Sarsik Enrolling by invitation No outcome recorded
Phase 4 NCT06832878 Jun 2026 overdue — Mayo Clinic Not yet recruiting No outcome recorded
Phase 4 NCT07614087 May → Jun 2026 overdue osteoarthritis Hua Luo Not yet recruiting No outcome recorded
Phase 4 NCT07501884 May → Dec 2026 expected urethral stricture Amjad Alwaal, MD, MSc, FRCSC, FACS Not yet recruiting No outcome recorded
Phase 4 NCT07115056 Apr 2026 → Dec 2028 — Campbell Clinic Withdrawn No outcome recorded
Phase 4 NCT07460518 Mar → Jun 2026 overdue anemia, benign prostatic hyperplasia Hamza Najout Not yet recruiting No outcome recorded
Phase 4 NCT07116395 Jan 2026 → Jun 2029 expected — Arbi Nazarian, MD Not yet recruiting No outcome recorded
Phase 4 NCT07314424 Jan 2026 → Oct 2027 expected anemia Tang Xiaodong Not yet recruiting No outcome recorded
Show all 137 trials opens the full record — a long page
Phase not applicable112 trials
— NCT07530016 Aug 2026 → Dec 2027 expected hyperpigmentation of the skin The First Affiliated Hospital of Xinxiang Medical College Not yet recruiting No outcome recorded
— NCT07714473 Aug → Nov 2026 expected rotator cuff syndrome Hua Luo Not yet recruiting No outcome recorded
— NCT07679139 Jul 2026 → Dec 2027 expected — National Cheng-Kung University Hospital Not yet recruiting No outcome recorded
— NCT07581457 Jun 2026 → May 2027 expected adolescent idiopathic scoliosis Poznan University of Medical Sciences Recruiting No outcome recorded
— NCT07494032 May 2026 → May 2029 expected arthropathy NYU Langone Health Not yet recruiting No outcome recorded
— NCT07540026 May 2026 → Dec 2027 expected upper digestive tract disorder National Cheng-Kung University Hospital Recruiting No outcome recorded
— NCT07432737 Feb 2026 → May 2027 expected bone disorder University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje Recruiting No outcome recorded
— NCT07390799 Feb → Aug 2026 overdue — Ege University Not yet recruiting No outcome recorded
— NCT07318467 Jan → Jun 2026 overdue — Cairo University Not yet recruiting No outcome recorded
— NCT07401394 Dec 2025 → Jun 2026 overdue hemorrhagic disease Santa Maria Hospital - GVM Care & Research Active not recruiting No outcome recorded
Show all 112 trials opens the full record — a long page
Also used as a comparator or background therapy in 248 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 06 trials
Phase 0 NCT07280234 Comparator Nov 2024 → May 2025 hyperpigmentation of the skin Hayat Abad Medical Complex, Peshawar Completed No outcome recorded
Phase 0 NCT06509256 Comparator Jul 2024 overdue urticaria Assiut University Not yet recruiting No outcome recorded
Phase 0 NCT06149091 Comparator Dec 2023 → Dec 2024 bronchial disorder China-Japan Friendship Hospital Unknown No outcome recorded
Phase 0 NCT06457360 Comparator Nov 2023 → Jan 2024 cirrhosis of liver British University In Egypt Completed No outcome recorded
Phase 0 NCT05427513 Comparator Apr 2022 → Dec 2023 — Shaukat Khanum Memorial Cancer Hospital & Research Centre Unknown No outcome recorded
Phase 17 trials
Phase 1 NCT07002749 Comparator Jun 2025 overdue — Patel Hospital, Pakistan Not yet recruiting No outcome recorded
Phase 1 NCT05884151 Comparator Nov 2022 → Apr 2023 hyperpigmentation of the skin Combined Military Hospital Abbottabad Completed No outcome recorded
Phase 1 NCT05887219 Comparator Nov 2022 → Apr 2023 hyperpigmentation of the skin Combined Military Hospital Abbottabad Completed No outcome recorded
Phase 1 NCT06920264 Comparator Jul 2021 → Sep 2024 — St. Louis Joint Replacement Institute Completed No outcome recorded
Phase 1 NCT05362500 Comparator Jun → Nov 2021 hyperpigmentation of the skin Combined Military Hospital Abbottabad Completed No outcome recorded
Phase 1/26 trials
Phase 1/2 NCT06330935 Comparator Mar 2024 → Mar 2025 traumatic brain injury Mansoura University Unknown No outcome recorded
Phase 1/2 NCT04656067 Comparator Apr → Oct 2020 — Egymedicalpedia Completed No outcome recorded
Phase 1/2 NCT04707950 Comparator Jan 2020 → Feb 2021 — Benha University Unknown No outcome recorded
Phase 1/2 NCT03780894 Background Nov 2018 → Jan 2021 — Blood and Tissue Bank of Catalonia Completed No outcome recorded
Phase 1/2 NCT02616731 Comparator Sep 2015 → Jan 2016 menstrual disorder Ain Shams University Unknown No outcome recorded
Phase 222 trials
Phase 2 NCT07127042 Comparator Aug 2025 → Dec 2026 expected — ScinnoHub Pharmaceutical Co., Ltd. Recruiting No outcome recorded
Phase 2 NCT07169383 Comparator Jun → Dec 2025 overdue hyperpigmentation of the skin Hina Malik Enrolling by invitation No outcome recorded
Phase 2 NCT07392034 Comparator Jan → Jun 2025 — Nishtar Medical University Completed No outcome recorded
Phase 2 NCT06479161 Comparator Jun 2024 → Feb 2025 overdue — Matthew Grosso, MD Recruiting No outcome recorded
Phase 2 NCT05909072 Comparator Jun → Nov 2023 hyperpigmentation of the skin Zagazig University Unknown No outcome recorded
Phase 2/311 trials
Phase 2/3 NCT07448415 Comparator Feb 2026 → Feb 2027 expected hyperpigmentation of the skin Assiut University Not yet recruiting No outcome recorded
Phase 2/3 NCT07245264 Comparator Dec 2025 → Nov 2028 expected — St. Olavs Hospital Recruiting No outcome recorded
Phase 2/3 NCT07125508 Comparator Aug 2023 → Sep 2024 anemia, angiodysplasia of intestine Louisiana State University Health Sciences Center in New Orleans Completed No outcome recorded
Phase 2/3 NCT04742205 Comparator Feb 2021 → Dec 2023 intracerebral hemorrhage Kathmandu Medical College and Teaching Hospital Completed No outcome recorded
Phase 2/3 NCT04562610 Comparator Nov 2020 → Oct 2024 vertebral column disorder University of California, Davis Completed No outcome recorded
Phase 342 trials
Phase 3 NCT05713630 Comparator May 2026 → Mar 2027 expected — Unity Health Toronto Recruiting No outcome recorded
Phase 3 NCT06622564 Comparator Jan 2025 → Jan 2026 overdue epilepsy, hemorrhagic disease Hamilton Health Sciences Corporation Not yet recruiting No outcome recorded
Phase 3 NCT05470816 Comparator Nov 2022 → Aug 2026 overdue dementia Bayside Health Active not recruiting No outcome recorded
Phase 3 NCT05648656 Comparator Feb 2022 → Jan 2023 — Post Graduate Institute of Medical Education and Research, Chandigarh Unknown No outcome recorded
Phase 3 NCT04344860 Comparator Jun 2021 → Aug 2024 von Willebrand disease (hereditary or acquired) Nicoletta C Machin Completed No outcome recorded
Phase 484 trials
Phase 4 NCT07522788 Comparator Jun → Nov 2026 expected hyperpigmentation of the skin Hayatabad Medical Complex Not yet recruiting No outcome recorded
Phase 4 NCT06894719 Comparator Jun → Dec 2026 expected — Rush University Medical Center Not yet recruiting No outcome recorded
Phase 4 NCT07332910 Comparator Jan → Jun 2026 overdue hemarthrosis Chirec Not yet recruiting No outcome recorded
Phase 4 NCT07078942 Comparator Jul 2025 → Jul 2026 overdue — Chulalongkorn University Not yet recruiting No outcome recorded
Phase 4 NCT07089251 Comparator Jul 2025 → Jun 2027 expected osteoarthritis, knee King Abdullah International Medical Research Center Recruiting No outcome recorded
Phase not applicable70 trials
— NCT07495748 Comparator Jul → Dec 2026 expected hyperpigmentation of the skin Foundation University Islamabad Not yet recruiting No outcome recorded
— NCT07540702 Comparator Feb → Aug 2026 overdue hyperpigmentation of the skin Kasr El Aini Hospital Recruiting No outcome recorded
— NCT07365150 Comparator Jan 2026 → Jun 2027 expected intracerebral hemorrhage The University of Hong Kong Recruiting No outcome recorded
— NCT07192640 Comparator Oct 2025 → Feb 2026 overdue hemorrhagic disease, obesity disorder Ain Shams University Not yet recruiting No outcome recorded
— NCT06208267 Comparator Aug 2025 → Apr 2027 expected esophageal varices with bleeding St. Mary's Research Center, Canada Recruiting No outcome recorded

Evidence & citations 37 cited values

Every value below carries the sentence it was read from. 770 sources stand behind the page.

FieldValueCited text
Known as Tranexamic Acid “Effects of Co-administered Sublingual Misoprostol and Intravenous Tranexamic Acid on Prevention of Postpartum Hemorrhage in Pregnant Women With Twin Pregnancy Undergoing...” NCT03774524 ↗
684

“Whole Blood Clot Stability and Thrombin Generating Capacity Following Treatment With Bypassing Agents (BPA) With and Without and Tranexamic Acid (TXA) in Haemophilia A Patients...” NCT01800435 ↗

“The aim of this study is to compare the effectiveness of combined tranexamic acid (TA) and oxytocin infusion with intravenous carbetocin for prevention of PPH in patients with...” NCT03777878 ↗

“OBJECTIVE: To estimate the effects of adding intravenous tranexamic acid (TA) to the standard active management of third-stage labor to reduce vaginal blood loss during the...” PMID 23023559 ↗ Sep 2012

“Tranexamic acid (TXA) has been routinely delivered in multisegmental spinal decompression and bone graft fusion surgeries with satisfactory outcomes in minimizing gross blood...” PMID 30755256 ↗ Feb 2019

“Patients in the experimental group will receive a loading dose of tranexamic acid (TXA) at a concentration of 1g/10ml over a period of 10 minutes, administered immediately...” NCT05794321 ↗

“Group (II): patients received 1 gm tranexamic acid (TA), (2 ampoules of Capron® 500 mg /5 ml; Cairo, Egypt) intravenous just before skin incision plus Intrauterine Inflated...” NCT03741114 ↗

“10 mg/kg tranexamic acid (Transamine 10% IV/IM Injectable Solution) will be placed into 100 cc physiological saline through the appropriate vascular access and injected within...” NCT06434636 ↗

“Tranexamic acid will be given as per unit protocol, (currently 1g pre-operatively IV and 500mg orally at 8 hours post op. unless contraindicated by a high risk of thrombosis.)” NCT02288923 ↗

“To determine whether intraoperative tranexamic acid (TXA) administration reduced intraoperative blood loss in patients undergoing large meningioma resection.” PMID 42115323 ↗ May 2026

“Patient will receive an intravenous perfusion of 300 mg Exacyl (tranexamic acid) intravenous (IV) over 9 minutes, starting at the time of surgical incision.” NCT03822793 ↗

“Oral administration of 2 grammes tranexamic acid 2 hours before skin incision and 2 grammes oral tranexamic acid 4 hours after first administration” NCT04855877 ↗

“Tranexamic acid (TXA) is a drug that has proved useful in reducing bleeding associated with other surgeries and CRT results have been positive” NCT01199627 ↗

“Subjects will be given the therapeutic dose of tranexamic acid for menorrhagia, which is 1300 mg PO TID for up to 5 days during menstruation” NCT05309525 ↗

“single dose of 20ug/kg of recombinant factor VIIa along with tranexamic acid of 4 gram a day for 7 days following surgery” NCT01538160 ↗

“Tranexamic acid (Amchafibrin) exerts an antihemorrhagic activity by inhibiting the fibrinolytic properties of plasmin.” NCT03386656 ↗

“These medications are Ofirmev ( acetaminophen ) 1,000mg and tranexamic acid 2,000 mg , an antifibrinolytic drug.” NCT04562610 ↗

“Intravenous and topical tranexamic acid (TXA) have been well established in reducing blood loss postoperatively.” NCT03074994 ↗

“Tranexamic acid (TA) is an antifibrinolytic agent that blocks the lysine-binding site of plasminogen to fibrin.” NCT03870256 ↗

“Tranexamic acid and Etamsylate are slowly given intravenously 10 minutes before start of Cesarean Delivery” NCT05273632 ↗

“Patients randomized to the IV TXA group will receive intravenous Tranexamic acid during the procedure.” NCT07131592 ↗

“Tranexamic acid (TXA) reduces blood loss and transfusion in paediatric craniosynostosis surgery.” PMID 32620262 ↗ Jun 2020

“Tranexamic acid will be used in aconcentration of 4mg/ml ,1ml will be used fo half of the face.” NCT03923062 ↗

“A gauze soaked with 2 g tranexamic acid (20 ml) diluted in 100 ml of sodium chloride0.9%” NCT03880045 ↗

“Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy” NCT00657384 ↗

“Topical tranexamic acid (TXA) and ascorbic acid are both effective in treating melasma” NCT07522788 ↗

“0.5g of tranexamic acid is administered locally after dilution before surgical closure” NCT07314424 ↗

“Tranexamic acid (TXA) reduces bleeding and transfusion requirements in established PPH” PMID 36934142 ↗ Mar 2023

“Intravenous tranexamic acid (TXA) reduces bleeding deaths after injury and childbirth.” PMID 33010927 ↗ Sep 2020

“will receive 1 g tranexamic acid (2 ampoules of kapron 500 mg, kapron®, Amoun, Egypt)” NCT05806307 ↗

“Intraosseous injection of Ketorolac 15mg and Tranexamic acid 500mg in femoral canal” NCT06243575 ↗

“2g of sucralfate powder and 1g of tranexamic acid powder will be sprayed after EST” NCT06107504 ↗

“Tranexamic acid (TXA), an antifibrinolytic agent, reduces perioperative bleeding” NCT07288697 ↗

“the use of topical and intravenous (IV) Tranexamic Acid (TXA) in spine surgery.” NCT02093988 ↗

“1.3 mg oral tranexamic acid or 1.0 mg oral estradiol three times a day” NCT01659008 ↗

“tranexamic acid (TXA) nebulization to control bleeding in hemoptysis.” PMID 41221568 ↗ Oct 2025

“1-gram tranexamic acid (10 ml) in 100 ml saline infusion” NCT03880604 ↗

“Tranexamic acid belongs to fibrinolytic inhibitors.” NCT00308880 ↗

“1 gm of tranexamic acid in 100 ml saline iv” NCT03777696 ↗

“Tranexamic acid intravenous administration” NCT05806346 ↗

“Tranexamic acid injection 8-10mg/kg” NCT05957822 ↗

“Tranexamic Acid 500 mg” NCT06369012 ↗

“tranexamic acid(TXA)” NCT05138913 ↗

“Tranexamic Acid” NCT03825939 ↗

NCT03553186 ↗

NCT03765021 ↗

NCT04338074 ↗

NCT06894719 ↗

NCT05072873 ↗

NCT02781597 ↗

NCT06000423 ↗

NCT02930941 ↗

NCT03109652 ↗

NCT01651182 ↗

NCT05429580 ↗

NCT06479161 ↗

NCT07442643 ↗

NCT02063035 ↗

NCT03353259 ↗

NCT01713101 ↗

NCT05874583 ↗

NCT02286973 ↗

NCT07423156 ↗

NCT04907812 ↗

NCT04898712 ↗

NCT01370460 ↗

NCT02053363 ↗

NCT04986813 ↗

NCT03741075 ↗

NCT04560465 ↗

NCT03899233 ↗

NCT04549012 ↗

NCT06618820 ↗

NCT03690037 ↗

NCT02780245 ↗

NCT00994994 ↗

NCT07089251 ↗

NCT06580509 ↗

NCT01940523 ↗

NCT03060889 ↗

NCT04488367 ↗

NCT04753151 ↗

NCT07002749 ↗

NCT04489108 ↗

NCT03019198 ↗

NCT04373603 ↗

NCT01940419 ↗

NCT03580018 ↗

NCT01940536 ↗

NCT05913466 ↗

NCT02903017 ↗

NCT04319614 ↗

NCT02908516 ↗

NCT01085006 ↗

NCT03112135 ↗

NCT04951128 ↗

NCT03216083 ↗

NCT03580590 ↗

NCT07192640 ↗

NCT02146456 ↗

NCT04427618 ↗

NCT02026297 ↗

NCT06736860 ↗

NCT03970213 ↗

NCT04724772 ↗

NCT04187014 ↗

NCT04372940 ↗

NCT04149171 ↗

NCT01813058 ↗

NCT04494126 ↗

NCT02561923 ↗

NCT06088407 ↗

NCT02125890 ↗

NCT04754230 ↗

NCT03656445 ↗

NCT06091891 ↗

NCT04560010 ↗

NCT07672158 ↗

NCT00755209 ↗

NCT04771923 ↗

NCT03413891 ↗

NCT05397652 ↗

NCT03632824 ↗

NCT04089865 ↗

NCT03326596 ↗

NCT01658124 ↗

NCT03463993 ↗

NCT01881568 ↗

NCT02422056 ↗

NCT03774706 ↗

NCT06519422 ↗

NCT03113253 ↗

NCT04559880 ↗

NCT03708497 ↗

NCT03801122 ↗

NCT07157631 ↗

NCT06777966 ↗

NCT01655927 ↗

NCT04742205 ↗

NCT01651806 ↗

NCT03328832 ↗

NCT02829346 ↗

NCT02492087 ↗

NCT04610164 ↗

NCT01683955 ↗

NCT06301204 ↗

NCT00375258 ↗

NCT01655641 ↗

NCT05672407 ↗

NCT03582293 ↗

NCT03934047 ↗

NCT06644079 ↗

NCT07390799 ↗

NCT06109155 ↗

NCT01683747 ↗

NCT02427412 ↗

NCT01258010 ↗

NCT03540368 ↗

NCT03856164 ↗

NCT01599468 ↗

NCT05639686 ↗

NCT02650856 ↗

NCT02261415 ↗

NCT05072860 ↗

NCT02584725 ↗

NCT02627560 ↗

NCT06188052 ↗

NCT01846507 ↗

NCT03585179 ↗

NCT05448456 ↗

NCT04100447 ↗

NCT04550338 ↗

NCT03182751 ↗

NCT06653699 ↗

NCT06270407 ↗

NCT05302986 ↗

NCT03965767 ↗

NCT06509256 ↗

NCT06452342 ↗

NCT01964781 ↗

NCT04188184 ↗

NCT01873768 ↗

NCT06421389 ↗

NCT05909072 ↗

NCT06657924 ↗

NCT01326403 ↗

NCT01067638 ↗

NCT02219152 ↗

NCT01596738 ↗

NCT03361345 ↗

NCT06718751 ↗

NCT03469947 ↗

NCT05594186 ↗

NCT06149091 ↗

NCT03351686 ↗

NCT02966236 ↗

NCT07392034 ↗

NCT01937559 ↗

NCT01998438 ↗

NCT03646474 ↗

NCT06622564 ↗

NCT01060176 ↗

NCT05554211 ↗

NCT00375466 ↗

NCT04902950 ↗

NCT06070350 ↗

NCT05236569 ↗

NCT02840097 ↗

NCT00375440 ↗

NCT04911413 ↗

NCT02625948 ↗

NCT02314988 ↗

NCT04803747 ↗

NCT05598086 ↗

NCT02936661 ↗

NCT04803591 ↗

NCT06983886 ↗

NCT04419246 ↗

NCT07448415 ↗

NCT05075200 ↗

NCT05507983 ↗

NCT03849443 ↗

NCT05441592 ↗

NCT03570710 ↗

NCT01094977 ↗

NCT07263841 ↗

NCT02335359 ↗

NCT02797119 ↗

NCT01005147 ↗

NCT01519245 ↗

NCT04625530 ↗

NCT04541303 ↗

NCT04367155 ↗

NCT00147862 ↗

NCT06266546 ↗

NCT03280212 ↗

NCT04710017 ↗

NCT03070847 ↗

NCT05321199 ↗

NCT02775773 ↗

NCT00904709 ↗

NCT06384456 ↗

NCT03825939 ↗

NCT04555343 ↗

NCT05362500 ↗

NCT04387305 ↗

NCT03897621 ↗

NCT01064167 ↗

NCT05489185 ↗

NCT02926651 ↗

NCT06587620 ↗

NCT02327117 ↗

NCT01530399 ↗

NCT00809393 ↗

NCT05919615 ↗

NCT01031992 ↗

NCT07034560 ↗

NCT03425799 ↗

NCT00378872 ↗

NCT02540226 ↗

NCT01260818 ↗

NCT01980355 ↗

NCT03738527 ↗

NCT02080494 ↗

NCT01600599 ↗

NCT06414031 ↗

NCT07679139 ↗

NCT06097611 ↗

NCT04430777 ↗

NCT04918576 ↗

NCT02150720 ↗

NCT02252497 ↗

NCT06330935 ↗

NCT06086444 ↗

NCT03385928 ↗

NCT03806556 ↗

NCT05345613 ↗

NCT02938962 ↗

NCT01594671 ↗

NCT06010368 ↗

NCT04192435 ↗

NCT03838328 ↗

NCT06057675 ↗

NCT03963466 ↗

NCT06665594 ↗

NCT06345833 ↗

NCT06025916 ↗

NCT04042688 ↗

NCT05562609 ↗

NCT04918589 ↗

NCT05326139 ↗

NCT05884151 ↗

NCT02825719 ↗

NCT06010810 ↗

NCT02580227 ↗

NCT02587845 ↗

NCT05774717 ↗

NCT04025736 ↗

NCT03458468 ↗

NCT02329756 ↗

NCT02117128 ↗

NCT03211286 ↗

NCT02702128 ↗

NCT06246422 ↗

NCT04400916 ↗

NCT00588133 ↗

NCT04290884 ↗

NCT05811676 ↗

NCT04272606 ↗

NCT06522984 ↗

NCT00722436 ↗

NCT04192643 ↗

NCT07164300 ↗

NCT07013812 ↗

NCT02504125 ↗

NCT06599762 ↗

NCT02354885 ↗

NCT05427513 ↗

NCT01408030 ↗

NCT07187258 ↗

NCT02312440 ↗

NCT03706339 ↗

NCT03085394 ↗

NCT05855590 ↗

NCT03360045 ↗

NCT04599205 ↗

NCT06067217 ↗

NCT05802238 ↗

NCT04707950 ↗

NCT02187120 ↗

NCT05323149 ↗

NCT01228136 ↗

NCT00111215 ↗

NCT05024253 ↗

NCT04290013 ↗

NCT03631355 ↗

NCT06638749 ↗

NCT02644473 ↗

NCT05357079 ↗

NCT02152917 ↗

NCT06145191 ↗

NCT04312880 ↗

NCT06902714 ↗

NCT07115056 ↗

NCT02733952 ↗

NCT04304625 ↗

NCT04537533 ↗

NCT02578901 ↗

NCT04274335 ↗

NCT06040853 ↗

NCT01306370 ↗

NCT03101124 ↗

NCT04595786 ↗

NCT02604719 ↗

NCT05841251 ↗

NCT03359525 ↗

NCT01167764 ↗

NCT05082142 ↗

NCT05899465 ↗

NCT06128330 ↗

NCT02568124 ↗

NCT06060327 ↗

NCT03714360 ↗

NCT03364491 ↗

NCT04410042 ↗

NCT05470816 ↗

NCT03317795 ↗

NCT07245264 ↗

NCT03565276 ↗

NCT04650698 ↗

NCT04622397 ↗

NCT03751163 ↗

NCT02805426 ↗

NCT04811313 ↗

NCT06707051 ↗

NCT06920264 ↗

NCT02164565 ↗

NCT04111822 ↗

NCT04178655 ↗

NCT02664909 ↗

NCT00327106 ↗

NCT02645552 ↗

NCT06820177 ↗

NCT02153593 ↗

NCT02503319 ↗

NCT05099276 ↗

NCT05439694 ↗

NCT03777488 ↗

NCT05713630 ↗

NCT06710327 ↗

NCT03310060 ↗

NCT00827931 ↗

NCT04360629 ↗

NCT04766996 ↗

NCT04594408 ↗

NCT05248321 ↗

NCT03697681 ↗

NCT02993341 ↗

NCT03122782 ↗

NCT02569658 ↗

NCT03251469 ↗

NCT01060189 ↗

NCT02806024 ↗

NCT03789422 ↗

NCT01060163 ↗

NCT05947435 ↗

NCT04628676 ↗

NCT07582341 ↗

NCT02620748 ↗

NCT03782350 ↗

NCT05897918 ↗

NCT05759156 ↗

NCT04996368 ↗

NCT04651166 ↗

NCT04311073 ↗

NCT01869413 ↗

NCT03892668 ↗

NCT01894334 ↗

NCT04733157 ↗

NCT06143787 ↗

NCT05887219 ↗

NCT03823417 ↗

NCT07610863 ↗

NCT02972294 ↗

NCT04905901 ↗

NCT01191554 ↗

NCT01850394 ↗

NCT05464394 ↗

NCT07685743 ↗

NCT01295294 ↗

NCT06435832 ↗

NCT05816668 ↗

NCT07169383 ↗

NCT07644923 ↗

NCT05518279 ↗

NCT02738073 ↗

NCT02122679 ↗

NCT01136590 ↗

NCT00740116 ↗

NCT03433144 ↗

NCT04947514 ↗

NCT07501884 ↗

NCT02453802 ↗

NCT04760301 ↗

NCT01895101 ↗

NCT03365999 ↗

NCT03552705 ↗

NCT03244423 ↗

NCT06280456 ↗

NCT03023189 ↗

NCT03606785 ↗

NCT01527968 ↗

NCT00279578 ↗

NCT03820206 ↗

NCT02438566 ↗

NCT06832878 ↗

NCT02739815 ↗

NCT01402882 ↗

NCT02911831 ↗

NCT05956769 ↗

NCT01190150 ↗

NCT04463966 ↗

NCT02094066 ↗

NCT02618382 ↗

NCT07434453 ↗

NCT00401193 ↗

NCT07686705 ↗

NCT00396760 ↗

NCT00444470 ↗

NCT01027546 ↗

NCT01727843 ↗

NCT05836831 ↗

NCT07641946 ↗

NCT07530016 ↗

NCT02922582 ↗

NCT03376061 ↗

NCT01280981 ↗

NCT07116395 ↗

NCT04961528 ↗

NCT02278263 ↗

NCT01535781 ↗

NCT00824564 ↗

NCT06648265 ↗

NCT06038981 ↗

NCT07125508 ↗

NCT01449552 ↗

NCT05840471 ↗

NCT07332910 ↗

NCT04358965 ↗

NCT02051686 ↗

NCT04797156 ↗

NCT02084342 ↗

NCT05807074 ↗

NCT07714473 ↗

NCT07362992 ↗

NCT06422273 ↗

NCT07474077 ↗

NCT04233749 ↗

NCT07495748 ↗

NCT02616731 ↗

NCT07614087 ↗

NCT04117243 ↗

NCT05434533 ↗

NCT05710146 ↗

NCT03287336 ↗

NCT03128866 ↗

NCT03606109 ↗

NCT02606045 ↗

NCT06183918 ↗

NCT04518163 ↗

NCT02323373 ↗

NCT03431805 ↗

NCT07581457 ↗

NCT06725732 ↗

NCT04814433 ↗

NCT03679481 ↗

NCT05945680 ↗

NCT07127042 ↗

NCT07712510 ↗

NCT00500656 ↗

NCT03885895 ↗

NCT03037515 ↗

NCT05686005 ↗

NCT06754371 ↗

NCT06516419 ↗

NCT02688127 ↗

NCT01702636 ↗

NCT02106962 ↗

NCT02428868 ↗

NCT02535949 ↗

NCT04357015 ↗

NCT02393963 ↗

NCT03780894 ↗

NCT02650791 ↗

NCT04653623 ↗

NCT04386642 ↗

NCT00670345 ↗

NCT01221909 ↗

NCT05708690 ↗

NCT03475342 ↗

NCT05817474 ↗

NCT04357002 ↗

NCT07455591 ↗

NCT04865380 ↗

NCT07365150 ↗

NCT06879353 ↗

NCT06427850 ↗

NCT02615366 ↗

NCT06760078 ↗

NCT03623789 ↗

NCT00985920 ↗

NCT02302456 ↗

NCT06289478 ↗

NCT04344860 ↗

NCT02747615 ↗

NCT07494032 ↗

NCT00958581 ↗

NCT04635007 ↗

NCT01622946 ↗

NCT07280234 ↗

NCT01111669 ↗

NCT06023212 ↗

NCT04785651 ↗

NCT07174895 ↗

NCT05467462 ↗

NCT04338126 ↗

NCT01866943 ↗

NCT03954860 ↗

NCT02350179 ↗

NCT02319915 ↗

NCT02860221 ↗

NCT02684851 ↗

NCT03505723 ↗

NCT02684812 ↗

NCT03710330 ↗

NCT03778242 ↗

NCT06229483 ↗

NCT07432737 ↗

NCT07098780 ↗

NCT03139422 ↗

NCT03846973 ↗

NCT06419075 ↗

NCT02393300 ↗

NCT03505502 ↗

NCT03653429 ↗

NCT03923959 ↗

NCT05370820 ↗

NCT02253810 ↗

NCT01714336 ↗

NCT06208267 ↗

NCT02056444 ↗

NCT05053867 ↗

NCT04521881 ↗

NCT05517590 ↗

NCT06450392 ↗

NCT07460518 ↗

NCT03710317 ↗

NCT07540702 ↗

NCT05474027 ↗

NCT07318467 ↗

NCT06337838 ↗

NCT03710304 ↗

NCT07212452 ↗

NCT06356948 ↗

NCT02653261 ↗

NCT00355108 ↗

NCT07078942 ↗

NCT02180321 ↗

NCT02279186 ↗

NCT04691362 ↗

NCT07261930 ↗

NCT02918201 ↗

NCT01248104 ↗

NCT04863339 ↗

NCT02233101 ↗

NCT03686787 ↗

NCT05504577 ↗

NCT07696806 ↗

NCT06379724 ↗

NCT06457360 ↗

NCT03795649 ↗

NCT03954314 ↗

NCT06997796 ↗

NCT04788121 ↗

NCT04350645 ↗

NCT04448184 ↗

NCT04630886 ↗

NCT07481682 ↗

NCT02229292 ↗

NCT02374398 ↗

NCT02458729 ↗

NCT05688020 ↗

NCT02864095 ↗

NCT01643135 ↗

NCT04443920 ↗

NCT03044041 ↗

NCT04055194 ↗

NCT02043132 ↗

NCT05340205 ↗

NCT03044184 ↗

NCT06881628 ↗

NCT04224116 ↗

NCT01496196 ↗

NCT06763094 ↗

NCT02655653 ↗

NCT04054687 ↗

NCT07540026 ↗

NCT04170088 ↗

NCT05921071 ↗

NCT05688111 ↗

NCT00671281 ↗

NCT01990768 ↗

NCT00386308 ↗

NCT06515535 ↗

NCT00872469 ↗

NCT06428682 ↗

NCT04697992 ↗

NCT05437822 ↗

NCT06604325 ↗

NCT01728636 ↗

NCT01428713 ↗

NCT04694677 ↗

NCT00113568 ↗

NCT02865174 ↗

NCT05047133 ↗

NCT02866838 ↗

NCT06290596 ↗

NCT02656472 ↗

NCT04656067 ↗

NCT07565753 ↗

NCT03136445 ↗

NCT04347122 ↗

NCT01089140 ↗

NCT02947529 ↗

NCT04910464 ↗

NCT01141127 ↗

NCT04201951 ↗

NCT02753816 ↗

NCT07625709 ↗

NCT02546648 ↗

NCT07401394 ↗

NCT02678208 ↗

NCT05705336 ↗

NCT04696224 ↗

NCT02086500 ↗
Known as 1,4-amino-carboxylic acid “1,4-amino-carboxylic acid (tranexamic acid)” PMID 23917458 ↗ Sep 2014
Known as Acide Tranexamique ClinicalTrials.gov intervention name — accepted as the source's own label NCT04085575 ↗
Known as AMCA “Tranexamic acid (AMCA) is a potent antifibrinolytic drug” PMID 3321402 ↗ 1987
Known as Amchafibrin “Tranexamic acid (Amchafibrin) exerts an antihemorrhagic activity by inhibiting the fibrinolytic properties of plasmin.” NCT03386656 ↗
Known as AXA “Tranexamic acid (AXA) and aminocaproic acid (EACA) are synthetic drugs derived from Lysine that competitively inhibit the lysine receptors in the plasminogen and plasmin...” NCT03365999 ↗
Known as Capron “Group (II): patients received 1 gm tranexamic acid (TA), (2 ampoules of Capron® 500 mg /5 ml; Cairo, Egypt) intravenous just before skin incision plus Intrauterine Inflated...” NCT03741114 ↗
3

“1 gm tranexamic acid (2 ampoules of Capron 500 mg /5 ml; Cairo, Egypt) intravenous just before skin incision” NCT03706339 ↗

“1 gm tranexamic acid (2 ampoules of Capron 500 mg /5 ml; Cairo, Egypt) intravenous just before skin incision” NCT03710330 ↗

“1 gm tranexamic acid (2 ampoules of Capron 500 mg /5 ml; Amoun, Cairo, Egypt)” NCT03570710 ↗
Known as Cyclokapron “Cyclokapron” NCT05323149 ↗
1

NCT00697385 ↗
Known as Cyklo-f “Tranexamic acid (Transamin), Cyklokapron, Exacyl, Cyklo-f) is a synthetic lysine derivative” PMID 12825966 ↗ 2003
Known as Cyklokapron “Patients in the TXA group will be given 15 mg/kg of tranexamic acid (Cyklokapron@; Amoun Pharmaceutical Co., SAE) slowly intravenously 30 min before surgery followed by 10 mg/...” NCT03892668 ↗
9

“Subjects will be randomized in a 1:1:1:1 ratio to receive either DepoTXA 400 mg, DepoTXA 800 mg, DepoTXA 1200 mg, or IV TXA (Cyklokapron® 1 gram).” NCT02922582 ↗

“Standard surgery using burr-hole procedure, irrigation and drainage combined withTranexamic acid (Cyklokapron) administration.” NCT03353259 ↗

“Tranexamic acid (Cyklokapron) is utilized extensively for menorrhagia in Australia and the United Kingdom.” NCT00111215 ↗

“1 gm of Tranexamic Acid (Cyklokapron) that will be dissolved in 50 ml of injectable 0.9% saline” NCT05913466 ↗

“Tranexamic acid (Transamin), Cyklokapron, Exacyl, Cyklo-f) is a synthetic lysine derivative” PMID 12825966 ↗ 2003

“topical tranexamic acid (TXA - Cyklokapron; Pfizer, New York, NY)” NCT05357079 ↗

“Tranexamic Acid Injection [Cyklokapron]” NCT05464394 ↗

“Tranexamic Acid (Cyklokapron)” NCT07245264 ↗

“Tranexamic Acid (Cyklokapron)” NCT02053363 ↗
Known as Cyklokapron (tranexamic acid) “Cyklokapron (tranexamic acid)” NCT01535781 ↗
Known as EXACYL “Patient will receive an intravenous perfusion of 300 mg Exacyl (tranexamic acid) intravenous (IV) over 9 minutes, starting at the time of surgical incision.” NCT03822793 ↗
7

“IV Tranexamic acid (Exacyl®): 1 gram diluted in 20 mL saline solution, in 30 minutes, five minutes before skin incision and a second 1 gram, 3 hours later.” NCT02428868 ↗

“Tranexamic acid (TA) (Exacyl® Sanofi France), an antifibrinolytic drug, reduces bleeding and transfusion need in major surgery and trauma (1).” NCT02797119 ↗

“intravenous administration of 10-mL of tranexamic acid (EXACYL® 1 g/10 ml I.V., solution injectable)” NCT03431805 ↗

“Tranexamic acid (Transamin), Cyklokapron, Exacyl, Cyklo-f) is a synthetic lysine derivative” PMID 12825966 ↗ 2003

“Active comparator : Tranexamic Acid (Exacyl)” NCT02252497 ↗

NCT02403596 ↗

NCT01940692 ↗
Known as Group T ClinicalTrials.gov intervention name — accepted as the source's own label NCT02003313 ↗
Known as Kapron “In Tranexamic group (n=111), patients will be given 1 gm (10 ml) TXA (Kapron, Amoun, Egypt) diluted in 20 ml of Glucose 5% (administered as intravenous infusion over 5 minutes,...” NCT06060327 ↗
6

“Women assigned to the study group will receive 1 gr of TXA injection (Kapron, AMOUN Pharmaceutical co.) given slowly I.V over 10 minutes before the operation.” NCT02350179 ↗

“Tranexamic acid (Kapron ampoules, 100 mg/mL) is diluted under aseptic conditions to a final concentration of 10 mg/mL” NCT07540702 ↗

“soaked in Tranexamic acid (Kapron, Amoun Pharmaceuticals SAE, Egypt. 5ml Amp, 100mg /1ml)” NCT05439694 ↗

“will receive 1 g tranexamic acid (2 ampoules of kapron 500 mg, kapron®, Amoun, Egypt)” NCT05806307 ↗

“using a sterile towel soaked with 2g tranexamic acid (Kapron, Amoun, Cairo, Egypt)” NCT06515535 ↗

“Tranexamic acid (Kapron, Amoun Pharmaceuticals SAE, Egypt. 5ml Amp, 100mg /1ml)” NCT05434533 ↗
Known as Kepron “Tranexamic acid (Kepron, Amoun, Egypt) was given slowly intravenously over 10 minutes just before the skin incision of elective cesarean section to group A.” NCT03351686 ↗
Known as LB1148 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02836470 ↗
3

NCT05056935 ↗

NCT05470387 ↗

NCT04390217 ↗
Known as Lysteda “Medications: tranexamic acid (Lysteda, Pierre Fabre Mexico) or aminocaproic acid (Amikar, Wyeth), as appropriate, will be administered orally three times (administering 2...” NCT03365999 ↗
Known as Marcan-Tranexamic Acid “Marcan-Tranexamic Acid 500 mg oral tablet over-encapsulated to match the placebo.” NCT05713630 ↗
Known as Sandoz-Tranexamic Acid “Sandoz-Tranexamic Acid 100 mg/mL solution for injection via intravenous (IV) added to a 100mL infusion bag of NaCl 0.9% and infused by slow intravenous injection over 20 minutes.” NCT05713630 ↗
Known as TNA “Tranexamic acid (TNA) is an antifibrinolytic agent that inhibits fibrinolysis by blocking the activation of plasminogen.” NCT07174895 ↗
1

“Despite the documented blood-saving effects of tranexamic acid (TNA) in total knee arthroplasty (TKA)” PMID 23592025 ↗ Apr 2013
Known as tnx acid “group 1 (TRANEXEL 250 mg/5 mL) patients administered 250 mg tnx acid during the whole bimaxillary orthognathic surgery” NCT06301204 ↗
Known as TRAN “BACKGROUND: To assess the equivalence of tranexamic acid (TRAN) versus synthetic oxytocin (OXY) in reducing post-partum blood loss, in full-term patients (37-42 weeks), at low...” PMID 38873634 ↗ May 2024
Known as Tranexam OrPha “Tranexamic acid 10mg/kg (Tranexam OrPha 1000 mg/10 ml, OrPha Swiss GmbH, Küsnacht, Switzerland) will be administered 15 -30 minutes prior to surgery followed by infusion of...” NCT04625530 ↗
Known as Tranexamic acid (CYKLOKAPRON) (Pfizer, New York, NY). “Tranexamic acid (CYKLOKAPRON) (Pfizer, New York, NY).” NCT06419075 ↗
Known as tranexamic acid (TXA) “tranexamic acid (TXA)” NCT05639686 ↗
1

NCT03063892 ↗